EMRYX
Price
$22.11
Change
+$0.71 (+3.32%)
Updated
Jun 18 closing price
Net Assets
386.75M
VEMIX
Price
$38.34
Change
+$0.52 (+1.37%)
Updated
Jun 18 closing price
Net Assets
162.82B
Interact to see
Advertisement

EMRYX vs VEMIX

EMRYX vs VEMIX Comparison Chart in %
View a ticker or compare two or three
VS
EMRYX vs. VEMIX commentary
Jun 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMRYX is a Hold and VEMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 163B vs. EMRYX (387M). VEMIX pays higher dividends than EMRYX: VEMIX (2.42) vs EMRYX (0.92). EMRYX was incepted earlier than VEMIX: EMRYX (16 years) vs VEMIX (26 years). EMRYX (1.27) is less costly to investors than VEMIX (0.06). EMRYX is a more actively managed with annual turnover of: 29.00 vs. VEMIX (6.00). EMRYX has a lower initial minimum investment than VEMIX: EMRYX (1000) vs VEMIX (5000000). EMRYX annual gain was more profitable for investors over the last year : 49.13 vs. VEMIX (28.48). VEMIX return over 5 years is better than : 26.22 vs. EMRYX (10.43).
EMRYXVEMIXEMRYX / VEMIX
Total Expense Ratio1.110.061,850%
Annual Report Gross Expense Ratio1.270.062,117%
Fund Existence16 years26 years-
Gain YTD26.63213.118203%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets387M163B0%
Annual Yield % from dividends0.922.4238%
Returns for 1 year49.1328.48173%
Returns for 3 years67.8348.90139%
Returns for 5 years10.4326.2240%
Returns for 10 years100.19110.6491%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOHX20.480.38
+1.89%
Voya Large Cap Growth Port I
TRACX21.990.32
+1.48%
PGIM Quant Solutions Small-Cap Val C
MSCMX16.830.16
+0.96%
Morgan Stanley Insight C
OINCX26.150.06
+0.23%
JPMorgan Equity Income C
RYCFX46.850.03
+0.06%
Rydex Biotechnology C